-+ 0.00%
-+ 0.00%
-+ 0.00%

EMA'S CHMP: COMMITTEE RECOMMENDED TO EXTEND USE OF DUPIXENT (DUPILUMAB), FOR TREATMENT OF CHRONIC SPONTANEOUS URTICARIA IN CHILDREN AGED 2 TO 11 YRS

Reuters·02/27/2026 10:48:53

Please log in to view news